Beclometasone Dipropionate/Formoterol Fumarate

二丙酸倍氯米松/富马酸福莫特罗

Report date: 2026/05/08 20:02:52

Base Information

Drug NameBeclometasone Dipropionate/Formoterol Fumarate
Drug Alias NameBeclometasone Dipropionate/Formoterol fumarate二丙酸倍氯米松/富马酸福莫特罗吸入用倍氯米松福莫特罗气雾剂Beclometasone/formoterol - Chiesi FarmaceuticiBeclomethasone/formoterol +[27] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonistsBeta-2 adrenergic receptor agonistsImmunosuppressants
TargetsGlucocorticoid receptorBeta-2 adrenergic receptor
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Global Approved IndicationsAsthma
Approved Indications in ChinaAsthma
Original Approved Country/TerritoryMainland China
Original Approved Date2013/01/01
Country/TerritoryCzechiaBulgariaUnited States +[15] 
CombinationsYes Beclometasone DipropionateFormoterol Fumarate
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesChiesi Farmaceutici SPA
China Registration ClassN/A

Develop Information

Active CompaniesBayer AGChiesi Farmaceutici SPAChiesi Pharmaceutical Consulting (Shanghai) Co Ltd
Inactive CompaniesHefei Licheng Pharmaceutical Co LtdBeijing Kendlewits Medical Consulting Co LtdJewim Pharmaceutical (Shandong) Co Ltd +[4] 
Active IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Inactive IndicationsN/A

Other Information

ATC CodeR03AK08
Related LinksN/A